🇺🇸 FDA
Patent

US 8835639

Process for making modulators of cystic fibrosis transmembrane conductance regulator

granted A61PA61P1/00A61P1/10

Quick answer

US patent 8835639 (Process for making modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P1/00, A61P1/10, A61P1/16, A61P1/18